Last 1.76 NOK
Change Today -1.63 / -48.08%
Volume 20.6K
As of 10:25 AM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

cellcura asa (CELL) Snapshot

Open
1.84 NOK
Previous Close
3.39 NOK
Day High
1.85 NOK
Day Low
1.75 NOK
52 Week High
09/20/13 - 7.00 NOK
52 Week Low
08/11/14 - 1.40 NOK
Market Cap
11.5M
Average Volume 10 Days
56.0
EPS TTM
-5.80 NOK
Shares Outstanding
6.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CELLCURA ASA (CELL)

Related News

No related news articles were found.

cellcura asa (CELL) Related Businessweek News

No Related Businessweek News Found

cellcura asa (CELL) Details

CellCura ASA develops and sells equipment and products for use in assisted reproductive technology (ART) and stem cell research applications worldwide. The company offers CellCura ART lab solution, a track and trace system, which keeps track of embryos throughout the in-vitro process at various intervals, as well as provides a record of images, scoring, determinations, environmental conditions, and media and utensils from gamete collection to embryo replacement. It also offers CellCura software solutions, such as Morphology and image capture software that enables the embryologist to document the internal architecture of oocytes and embryos at various stages of their development using measurements and standard scoring parameters; and CellCura Protein Free Media, a culture media, which eliminates the risks of transmission of blood borne diseases. The company is headquartered in Skien, Norway.

2 Employees
Last Reported Date: 05/9/14

cellcura asa (CELL) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

cellcura asa (CELL) Key Developments

CellCura ASA Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

CellCura ASA reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported total operating income of NOK 404,000 against NOK 1,983,000 a year ago. Operating loss was NOK 4,740,000 against NOK 5,892,000 a year ago. Loss before tax was NOK 5,434,000 against NOK 6,450,000 a year ago. Loss was NOK 5,266,000 or NOK 0.81 per basic and diluted share against NOK 6,365,000 or NOK 1.94 per basic and diluted share a year ago. LBITDA was NOK 3.0 million compared to NOK 4.1 million a year ago. For the six months, the company reported total operating income of NOK 1,011,000 against NOK 3,788,000 a year ago. Operating loss was NOK 7,209,000 against NOK 11,376,000 a year ago. Loss before tax was NOK 8,570,000 against NOK 12,362,000 a year ago. Loss was NOK 8,286,000 or NOK 1.27 per basic and diluted share against NOK 12,153,000 or NOK 3.70 per basic and diluted share a year ago. Net cash flow used in operating activities was NOK 2,177,000 against NOK 4,324,000 a year ago.

CellCura ASA, Q2 2014 Earnings Call, Aug 29, 2014

CellCura ASA, Q2 2014 Earnings Call, Aug 29, 2014

CellCura ASA Announces Termination of Market Making Agreement with Norne Securities

CellCura ASA announced the market making agreement with Norne Securities has been cancelled, effective from July 10, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CELL:NO 1.76 NOK -1.63

CELL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CELL.
View Industry Companies
 

Industry Analysis

CELL

Industry Average

Valuation CELL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 13.5x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELLCURA ASA, please visit www.cellcura.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.